Correction to: Impact of nonoptimal intakes of saturated, polyunsaturated, and trans fat on global burdens of coronary heart disease. [J Am Heart Assoc. (2016) 5, e002891.] Doi:10.1161/JAHA.115.002891Wang, Qianyi; Afshin, Ashkan; Yakoob, Mohammad Yawar; Singh, Gitanjali M.; Rehm, Colin D.; Khatibzadeh, Shahab; Micha, Renata; Vaask, SirjeJournal of the American Heart Association2016 / p. 1 https://doi.org/10.1161/JAHA.115.002076 Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS

Lipoprotein-associated phospholipase A2 activity is a marker of risk but not a useful target for treatment in patients with stable coronary heart diseaseWallentin, Lars; Held, Claes; Armstrong, Paul W.; Cannon, Christopher Paul; Davies, Richard Y.; Granger, Christopher B.; Hagström, Emil; Harrington, Robert A.; Viigimaa, MargusJournal of the American Heart Association2016 / art. e003407 https://doi.org/10.1161/JAHA.116.003407 Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS